Xenon Pharmaceuticals Inc. (XENE) Net margin 2016–2025
Xenon Pharmaceuticals Inc. (XENE) net profit margin by fiscal year — reported net income divided by reported revenue.
-4612.1%FY2025 · since FY2016: -1275.5% → -4612.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4612.1% | — |
| FY2022 | -1328.9% | -901.1 pp |
| FY2021 | -427.8% | -338.2 pp |
| FY2020 | -89.7% | +519.4 pp |
| FY2019 | -609.1% | — |
| FY2017 | -9872.7% | -8597.2 pp |
| FY2016 | -1275.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice